Valeritas partners with the American Association of Diabetes Educators (AADE)
April 01, 2019 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., April 01, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas Announces V-Go® Distribution Agreement in Israel
March 28, 2019 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., March 28, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas to Present at the Oppenheimer 29th Annual Healthcare Conference
March 12, 2019 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., March 12, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas Reports Fourth Quarter and Full Year 2018 Financial Results
March 05, 2019 16:05 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., March 05, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
February 28, 2019 16:05 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Switching to Valeritas’ V-Go® Wearable Insulin Delivery Device from Insulin Pen Devices for Basal-Bolus Therapy Improved Glycemic Control with Less Insulin
February 21, 2019 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas to Present at Upcoming Investor Conferences
February 19, 2019 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas to Report Fourth Quarter and Full Year 2018 Financial Results on March 5, 2019
February 12, 2019 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas Announces V-Go® Received Preferred Status on OptumRx Formularies
January 14, 2019 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas Announces V-Go® is Preferred on Humana Part D Formularies
January 03, 2019 07:07 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, affordable,...